Clinical trials
Completed Phase 1/2 Amyloidosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2008 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mayo Clinic | 2 |
| Brigham and Women's Hospital | 1 |
| K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc. | 1 |
| Millennium Pharmaceuticals, Inc. | 1 |
| Nantes University Hospital | 1 |
| SOM Innovation Biotech SA | 1 |
| University College, London | 1 |
| University of Athens | 1 |
| University of Tennessee Graduate School of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amyloidosis | 10 |
| Immunoglobulin Light-chain Amyloidosis | 5 |
| Amyloid Neuropathies, Familial | 2 |
| Alzheimer Disease | 1 |
| Amyloidosis, Familial | 1 |
| Multiple Myeloma | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.